These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 28666735)

  • 1. Influence of the cellular environment on ligand binding kinetics at membrane-bound targets.
    Vanderheyden PML; Benachour N
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3621-3628. PubMed ID: 28666735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural determinants of subtype selectivity and functional activity of angiotensin II receptors.
    Sallander J; Wallinder C; Hallberg A; Åqvist J; Gutiérrez-de-Terán H
    Bioorg Med Chem Lett; 2016 Feb; 26(4):1355-9. PubMed ID: 26810314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand-supported homology modeling of the human angiotensin II type 1 (AT(1)) receptor: insights into the molecular determinants of telmisartan binding.
    Patny A; Desai PV; Avery MA
    Proteins; 2006 Dec; 65(4):824-42. PubMed ID: 17034041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of divalent cations on the porcine kidney cortex membrane-bound form of dipeptidyl peptidase IV.
    Pascual I; Gómez H; Pons T; Chappé M; Vargas MA; Valdés G; Lopéz A; Saroyán A; Charli JL; de los Angeles Chávez M
    Int J Biochem Cell Biol; 2011 Mar; 43(3):363-71. PubMed ID: 21093607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel aspects of cellular action of dipeptidyl peptidase IV/CD26.
    Ansorge S; Nordhoff K; Bank U; Heimburg A; Julius H; Breyer D; Thielitz A; Reinhold D; Täger M
    Biol Chem; 2011 Mar; 392(3):153-68. PubMed ID: 21194362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concentration-dependent plasma protein binding of the novel dipeptidyl peptidase 4 inhibitor BI 1356 due to saturable binding to its target in plasma of mice, rats and humans.
    Fuchs H; Tillement JP; Urien S; Greischel A; Roth W
    J Pharm Pharmacol; 2009 Jan; 61(1):55-62. PubMed ID: 19126297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substituted piperidinyl glycinyl 2-cyano-4,5-methano pyrrolidines as potent and stable dipeptidyl peptidase IV inhibitors.
    Zhao G; Kwon C; Wang A; Robertson JG; Marcinkeviciene J; Parker RA; Kirby MS; Hamann LG
    Bioorg Med Chem Lett; 2013 Mar; 23(6):1622-5. PubMed ID: 23416006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovering novel α-aminoacyl-containing proline derivatives with potent and selective inhibitory activity against dipeptidyl peptidase IV: design, synthesis, biological evaluation, and molecular modeling.
    Zhang X; Wang J; Su M; Li Z; Li J; Li J; Liu H
    Chem Biol Drug Des; 2012 Dec; 80(6):843-52. PubMed ID: 22726613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico approaches to predict the potential of milk protein-derived peptides as dipeptidyl peptidase IV (DPP-IV) inhibitors.
    Nongonierma AB; Mooney C; Shields DC; FitzGerald RJ
    Peptides; 2014 Jul; 57():43-51. PubMed ID: 24793774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of novel xanthine compounds targeting DPP-IV and GPR119 as anti-diabetic agents.
    Li G; Huan Y; Yuan B; Wang J; Jiang Q; Lin Z; Shen Z; Huang H
    Eur J Med Chem; 2016 Nov; 124():103-116. PubMed ID: 27560285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of (arene)Ru(II) complexes of curcumin as inhibitors of dipeptidyl peptidase IV.
    Antonyan A; De A; Vitali LA; Pettinari R; Marchetti F; Gigliobianco MR; Pettinari C; Camaioni E; Lupidi G
    Biochimie; 2014 Apr; 99():146-52. PubMed ID: 24316375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel series of 3-amino-N-(4-aryl-1,1-dioxothian-4-yl)butanamides as potent and selective dipeptidyl peptidase IV inhibitors.
    Nitta A; Fujii H; Sakami S; Satoh M; Nakaki J; Satoh S; Kumagai H; Kawai H
    Bioorg Med Chem Lett; 2012 Dec; 22(23):7036-40. PubMed ID: 23072865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Analysis of Binding Kinetics and Thermodynamics of Dipeptidyl Peptidase-4 Inhibitors and Their Relationship to Structure.
    Schnapp G; Klein T; Hoevels Y; Bakker RA; Nar H
    J Med Chem; 2016 Aug; 59(16):7466-77. PubMed ID: 27438064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the molecular dynamics of type-2 diabetes drug target DPP-4 and its interaction with Sitagliptin and inhibitor Diprotin-A.
    Chakraborty C; Hsu MJ; Agoramoorthy G
    Cell Biochem Biophys; 2014 Nov; 70(2):907-22. PubMed ID: 24809328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Navigating the chemical space of dipeptidyl peptidase-4 inhibitors.
    Shoombuatong W; Prachayasittikul V; Anuwongcharoen N; Songtawee N; Monnor T; Prachayasittikul S; Prachayasittikul V; Nantasenamat C
    Drug Des Devel Ther; 2015; 9():4515-49. PubMed ID: 26309399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation into the bioavailability of milk protein-derived peptides with dipeptidyl-peptidase IV inhibitory activity using Caco-2 cell monolayers.
    Lacroix IME; Chen XM; Kitts DD; Li-Chan ECY
    Food Funct; 2017 Feb; 8(2):701-709. PubMed ID: 28098291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging concepts of regulation of angiotensin II receptors: new players and targets for traditional receptors.
    Mogi M; Iwai M; Horiuchi M
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2532-9. PubMed ID: 17717300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural determinants for binding, activation, and functional selectivity of the angiotensin AT1 receptor.
    Balakumar P; Jagadeesh G
    J Mol Endocrinol; 2014 Oct; 53(2):R71-92. PubMed ID: 25013233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of milk protein-derived peptides to dipeptidyl peptidase IV (DPP-IV) hydrolysis.
    Nongonierma AB; FitzGerald RJ
    Food Chem; 2014 Feb; 145():845-52. PubMed ID: 24128555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of all eight stereoisomers of DPP-IV inhibitor saxagliptin.
    Dong J; Gong Y; Liu J; Chen X; Wen X; Sun H
    Bioorg Med Chem; 2014 Feb; 22(4):1383-93. PubMed ID: 24457090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.